Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 35

Sort by

Sort Order Select

Journal Articles

Mir-485-3p and Mir-654-3p Expression in Bone Marrow Mesenchymal Stromal Cells in Patients with Monoclonal Gammopathies Is Related to the Status of the Disease

Carlos Fernandez de Larrea, MD PhD, Tania Diaz, PhD, Alfons Navarro, PhD, Ester Lozano, PhD, Mari-Pau Mena, PhD, Ignacio Isola, MD, Natalia Tovar, MD PhD, Maria Teresa Cibeira, MD PhD, Laura Rosinol, MD PhD, Joan Bladé, MD PhD

Blood (2018) 132 (Supplement 1): 3155.

https://doi.org/10.1182/blood-2018-99-112222

Published: 2018

Journal Articles

Micrornas in Bone Marrow Mesenchymal Stromal Cells Are Differentially Expressed According to Response in Multiple Myeloma

Carlos Fernandez de Larrea, MD PhD, Tania Diaz, PhD, Alfons Navarro, PhD, Ester Lozano, PhD, Mari-Pau Mena, PhD, Ignacio Isola, MD, Mª Teresa Cibeira, MD PhD, Laura Rosinol, MD PhD, Joan Bladé, MD PhD

Blood (2017) 130 (Supplement 1): 4362.

https://doi.org/10.1182/blood.V130.Suppl_1.4362.4362

Published: 2017

Journal Articles

Exploring the Expression Profile of Long Non-Coding RNA (lncRNA) in Different Acute Myeloid Leukemia (AML) Subtypes: t(8;16)(p11;p13)/MYST3-Crebbp AML Harbors a Distinctive Lncrna Signature

Marina Diaz-Beya, MD PhD, Alfons Navarro, Anna Cordeiro, Marta Pratcorona, Joan Castellano, Miguel Angel Torrente, Meritxell Nomdedeu, Ruth Risueño, Maria Rozman, Mariano Monzo, Jordi Esteve, MD PhD

Blood (2015) 126 (23): 1397.

https://doi.org/10.1182/blood.V126.23.1397.1397

Published: 2015

Journal Articles

Salvage Therapy for Multiple Myeloma with Lenalidomide-Based Regimens: Impact of Single Nucleotide Polymorphisms Related to miRNA Pathways

Carlos Fernández de Larrea, MD PhD, Tania Díaz, PhD, María Teresa Cibeira, MD PhD, Natalia Tovar, MD, Alfons Navarro, PhD, Laura Rosiñol, MD PhD, Raquel Jiménez, MD, Rut Tejero, PhD, Mariano Monzó, MD PhD, Joan Bladé, MD PhD

Blood (2014) 124 (21): 2045.

https://doi.org/10.1182/blood.V124.21.2045.2045

Published: 2014

Journal Articles

Piwirna-651 Expression Influences Treatment Response and Impacts Survival in Classical Hodgkin Lymphoma Patients through Regulation of ABCC5

Alfons Navarro, PhD, Anna Cordeiro, Msc, Anna Gaya, MD, Blanca Gonzalez-Farre, MD, Marina Díaz-Beyá, MD PhD, Dolors Fuster, Carmen Martínez, MD, Jordi Esteve, MD PhD, Antonio Martinez, MD, Mariano Monzó, MD PhD

Blood (2014) 124 (21): 134.

https://doi.org/10.1182/blood.V124.21.134.134

Published: 2014

Journal Articles

The LincRNA HOTAIRM1 , Located in the HOXA genomic Region , impacts Prognosis in Acute Myeloid Leukemia and Is Associated with a Distinctive microRNA Signature

Marina Díaz-Beyá, MD PhD, Alfons Navarro, PhD, Salut Brunet, MD PhD, Josep F Nomdedeu, MD, Anna Cordeiro, Msc, Marta Pratcorona, MD PhD, Meritxell Nomdedeu, MD PhD, Ruth M Risueño, PhD, Josep-Maria Ribera, MD PhD, Mar Tormo, MDPhD, Rafael F. Duarte, MD PhD, Olga Salamero, MD, Lourdes Escoda, MD, David Gallardo, MD PhD, Carmen Pedro, MD, Josep M Marti-Tutusaus, Jorge Sierra, MD, Mariano Monzó, MD PhD, Jordi Esteve, MD PhD

Blood (2014) 124 (21): 1003.

https://doi.org/10.1182/blood.V124.21.1003.1003

Published: 2014

Journal Articles

BAALC -Associated Mir-3151 Is An Independent Prognostic Factor In Younger Patients With Intermediate-Risk Cytogenetic Acute Myeloid Leukemia

Marina Díaz-Beyá, MD, Alfons Navarro, PhD, Marta Pratcorona, MD, Salut Brunet, MD, PhD, Josep F Nomdedeu, MD, Josep-Maria Ribera, MD, PhD, Mar Tormo, MD, Rafael F. Duarte, MD, PhD, Olga Salamero, MD, David Gallardo, MD, PhD, Lourdes Escoda, Meritxell Nomdedeu, MD, PhD, Ruth M Risueño, PhD, Montserrat Hoyos, Francisco Cervantes, MD, PhD, Jorge Sierra, MD, PhD, Mariano Monzó, MD, PhD, Jordi Esteve, MD, PhD

Blood (2013) 122 (21): 2577.

https://doi.org/10.1182/blood.V122.21.2577.2577

Published: 2013

Journal Articles

A 40-Microrna Signature Characterizes JAK2 V617F-Negative Essential Thrombocythemia: Role Of Mir-221 and Mir-203 In The Regulation Of The JAK-STAT Pathway

Alfons Navarro, PhD, Silvia Pairet, Aina Pons, Gerardo Ferrer, PhD, Raquel Longarón, Alberto Alvarez-Larrán, Luz Martínez-Avilés, Concepcion Fernández-Rodríguez, Mariano Monzó, MD, PhD, Carlos Besses, MD, PhD, Beatriz Bellosillo

Blood (2013) 122 (21): 2846.

https://doi.org/10.1182/blood.V122.21.2846.2846

Published: 2013

Journal Articles

Prognostic Significance Of a 4-Microrna Signature Targeting JAK2 In Classical Hodgkin Lymphoma

Alfons Navarro, PhD, Anna Gaya, MD, Anna Cordeiro, Msc, Blanca Gonzalez-Farre, MD, Marina Díaz-Beyá, MD, Dolors Fuster, Carmen Martinez, Jordi Esteve, MD, PhD, Antonio Martinez, MD, Mariano Monzó, MD, PhD

Blood (2013) 122 (21): 629.

https://doi.org/10.1182/blood.V122.21.629.629

Published: 2013

Journal Articles

Overall Hydroxymethylation Levels As an Independent Prognostic Marker in Intermediate-Cytogenetic Risk Acute Myeloid Leukemia

Marina Díaz-Beyá, MD, Alfons Navarro, PhD, Rut Tejero, Marta Pratcorona, MD, Tania Díaz, PhD, Mariano Monzó, MD, PhD, Jordi Esteve, MD, PhD

Blood (2012) 120 (21): 1375.

https://doi.org/10.1182/blood.V120.21.1375.1375

Published: 2012

Journal Articles

Global Methylation Provides Independent Prognostic Information in Chronic Lymphocytic Leukemia and Is Associated with a Microrna Signature

Alfons Navarro, PhD, Gerardo Ferrer, PhD, Marina Díaz-Beyá, MD, Carmen Muñoz, PhD, Rut Tejero, Tania Díaz, PhD, Mariano Monzó, MD, PhD, Emili Montserrat, MD. PhD

Blood (2012) 120 (21): 3873.

https://doi.org/10.1182/blood.V120.21.3873.3873

Published: 2012

Journal Articles

Impact of Single Nucleotide Polymorphisms in Genes Involved in DNA Repair and Drug Metabolism On Survival After Autologous Stem Cell Transplantation in Patients with Multiple Myeloma.

Carlos Fernández de Larrea, Alfons Navarro, PhD, Natalia Tovar, Fabiola Pedrosa, Tania Díaz, PhD, María Teresa Cibeira, Laura Magnano, Laura Rosiñol, MD, Montserrat Rovira, María Rozman, Mariano Monzó, MD, PhD, Joan Blade, MD

Blood (2012) 120 (21): 2934.

https://doi.org/10.1182/blood.V120.21.2934.2934

Published: 2012

Journal Articles

Mir-SNP Haplotype in the MicroRNA Maturation Pathway As a Marker of Clinical Outcome in Hodgkin Lymphoma (HL)

Alfons Navarro, PhD, Carmen Muñoz, PhD, Anna Gaya, MD, Antonio Martinez, MD, Marina Díaz Beyá, MD, Rut Tejero, Tania Díaz, PhD, Gerardo Ferrer, Msc, Alvaro Urbano-Ispizua, MD, Mariano Monzó, MD, PhD

Blood (2011) 118 (21): 1561.

https://doi.org/10.1182/blood.V118.21.1561.1561

Published: 2011

Journal Articles

The Distinctive MicroRNA Signature of Acute Myeloid Leukemia with Translocation t(8;16)(p11;p13)/MYST3-CREBBP Is Responsible for RET Overexpression and Is Regulated by Epigenetic Mechanisms

Marina Díaz-Beyá, MD, Alfons Navarro, PhD, Tania Díaz, PhD, Gerardo Ferrer, Rut Tejero, Mireia Camós, MD, PhD, Montserrat Torrebadell, MD, Marta Pratcorona, MD, Maria Rozman, MD, PhD, Mariano Monzó, MD, PhD, Jordi Esteve, MD, PhD

Blood (2011) 118 (21): 2434.

https://doi.org/10.1182/blood.V118.21.2434.2434

Published: 2011

Journal Articles

MicroRNAs in Intermediate Risk Cytogenetic Acute Myeloid Leukemia Add Relevant Prognostic Information to Molecular Categorization

Marina Díaz-Beyá, MD, Alfons Navarro, PhD, Tania Díaz, PhD, Marta Pratcorona, MD, Maria Rozman, MD, PhD, Mariano Monzó, MD, PhD, Jordi Esteve, MD, PhD

Blood (2011) 118 (21): 235.

https://doi.org/10.1182/blood.V118.21.235.235

Published: 2011

Journal Articles

Chronic Lymphocytic Leukemia Associated with Autoimmune Hemolytic Anemia Is Characterized by a Distinctive miRNA Signature,

Gerardo Ferrer, Msc, Alfons Navarro, PhD, Kate E Hodgson, MBBS, MRCP, FRCPath, Dolors Colomer, MD. PhD, Marta Aymerich, MD. PhD, Tycho Baumann, MD, Arturo Pereira, MD. PhD, Mariano Monzó, MD, PhD, Carol Moreno, MD, PhD, Emili Montserrat, MD. PhD

Blood (2011) 118 (21): 3897.

https://doi.org/10.1182/blood.V118.21.3897.3897

Published: 2011

Journal Articles

Impact of Single Nucleotide Polymorphisms in Genes Involved in miRNA Network on Survival and Progression After Autologous Stem Cell Transplantation in Patients with Multiple Myeloma,

Carlos Fernández de Larrea, Alfons Navarro, PhD, Tania Díaz, PhD, María Teresa Cibeira, Rut Tejero, Natalia Tovar, Gerardo Ferrer, Msc, Laura Rosiñol, MD, Montserrat Rovira, María Rozman, Mariano Monzó, MD, PhD, Joan Blade

Blood (2011) 118 (21): 3945.

https://doi.org/10.1182/blood.V118.21.3945.3945

Published: 2011

Journal Articles

Impact of Global and Gene-Specific DNA Methylation Pattern in Relapsed Multiple Myeloma Patients Treated with Bortezomib

Carlos Fernández de Larrea, Beatriz Martin-Antonio, María Teresa Cibeira, Alfons Navarro, PhD, Natalia Tovar, Tania Díaz, PhD, Laura Rosiñol, MD, Mariano Monzó, MD, PhD, Alvaro Urbano-Izpizua, Joan Blade

Blood (2011) 118 (21): 132.

https://doi.org/10.1182/blood.V118.21.132.132

Published: 2011

Journal Articles

Impact on Response and Survival of DNA Repair Single Nucleotide Polymorphisms In Relapsed or Refractory Multiple Myeloma Patients Treated with Thalidomide

Carlos Fernández de Larrea, María Teresa Cibeira, Alfons Navarro, Tania Díaz, Dolors Fuster, Natalia Tovar, Laura Rosiñol, Mariano Monzó, Joan Blade

Blood (2010) 116 (21): 4041.

https://doi.org/10.1182/blood.V116.21.4041.4041

Published: 2010

Journal Articles

Lestaurtinib (CEP701) Inhibits Proliferation and Activates Apoptosis In Hodgkin Lymphoma Cells through Inhibition of the JAK/STAT Signaling Pathway

Alfons Navarro, PhD, Tania Díaz, Antonio Martinez, MD, PhD, Anna Gaya, MD, Mariano Monzó, MD, PhD

Blood (2010) 116 (21): 3919.

https://doi.org/10.1182/blood.V116.21.3919.3919

Published: 2010

NARROW

Mir-485-3p and Mir-654-3p Expression in Bone Marrow Mesenchymal Stromal Cells in Patients with Monoclonal Gammopathies Is Related to the Status of the Disease

Micrornas in Bone Marrow Mesenchymal Stromal Cells Are Differentially Expressed According to Response in Multiple Myeloma

Exploring the Expression Profile of Long Non-Coding RNA (lncRNA) in Different Acute Myeloid Leukemia (AML) Subtypes: t(8;16)(p11;p13)/MYST3-Crebbp AML Harbors a Distinctive Lncrna Signature

Salvage Therapy for Multiple Myeloma with Lenalidomide-Based Regimens: Impact of Single Nucleotide Polymorphisms Related to miRNA Pathways

Piwirna-651 Expression Influences Treatment Response and Impacts Survival in Classical Hodgkin Lymphoma Patients through Regulation of ABCC5

The LincRNA HOTAIRM1 , Located in the HOXA genomic Region , impacts Prognosis in Acute Myeloid Leukemia and Is Associated with a Distinctive microRNA Signature

BAALC -Associated Mir-3151 Is An Independent Prognostic Factor In Younger Patients With Intermediate-Risk Cytogenetic Acute Myeloid Leukemia

A 40-Microrna Signature Characterizes JAK2 V617F-Negative Essential Thrombocythemia: Role Of Mir-221 and Mir-203 In The Regulation Of The JAK-STAT Pathway

Prognostic Significance Of a 4-Microrna Signature Targeting JAK2 In Classical Hodgkin Lymphoma

Overall Hydroxymethylation Levels As an Independent Prognostic Marker in Intermediate-Cytogenetic Risk Acute Myeloid Leukemia

Global Methylation Provides Independent Prognostic Information in Chronic Lymphocytic Leukemia and Is Associated with a Microrna Signature

Impact of Single Nucleotide Polymorphisms in Genes Involved in DNA Repair and Drug Metabolism On Survival After Autologous Stem Cell Transplantation in Patients with Multiple Myeloma.

Mir-SNP Haplotype in the MicroRNA Maturation Pathway As a Marker of Clinical Outcome in Hodgkin Lymphoma (HL)

The Distinctive MicroRNA Signature of Acute Myeloid Leukemia with Translocation t(8;16)(p11;p13)/MYST3-CREBBP Is Responsible for RET Overexpression and Is Regulated by Epigenetic Mechanisms

MicroRNAs in Intermediate Risk Cytogenetic Acute Myeloid Leukemia Add Relevant Prognostic Information to Molecular Categorization

Chronic Lymphocytic Leukemia Associated with Autoimmune Hemolytic Anemia Is Characterized by a Distinctive miRNA Signature,

Impact of Single Nucleotide Polymorphisms in Genes Involved in miRNA Network on Survival and Progression After Autologous Stem Cell Transplantation in Patients with Multiple Myeloma,

Impact of Global and Gene-Specific DNA Methylation Pattern in Relapsed Multiple Myeloma Patients Treated with Bortezomib

Impact on Response and Survival of DNA Repair Single Nucleotide Polymorphisms In Relapsed or Refractory Multiple Myeloma Patients Treated with Thalidomide

Lestaurtinib (CEP701) Inhibits Proliferation and Activates Apoptosis In Hodgkin Lymphoma Cells through Inhibition of the JAK/STAT Signaling Pathway

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only